1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Guidance on the use of trastuzumab for the treatment of advanced breast cancer

Technology appraisal guidance [TA34] Published: 15 March 2002

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Overview
  • 1 Guidance
  • 2 Clinical Need and Practice
  • 3 The Technology
  • 4 Evidence
  • 5 Implications for the NHS
  • 6 Further Research
  • 7 Implementation
  • 8 Related Guidance
  • 9 Review of Guidance
  • Appendix A. Appraisal Committee Members
  • Appendix B. Sources of Evidence
  • Appendix C. Guidance on the use of trastuzumab for the treatment of advanced breast cancer. Patient information
  • Changes after publication
  • About this guidance
Download guidance (PDF)

Guidance

  • Next

6 Further Research

6 Further Research

6.1 Information linking side-effects associated with treatments with quality of life would enhance the comprehensiveness of future economic evaluations of treatments for advanced breast cancer.


  • Next